Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03673 |
| Species: | Homo sapiens |
| Position : | chr17:62028378-62028924 |
| Year: | 2011 |
| Title: | Enhancer-blocking activity is associated with hypersensitive site V sequences in the human growth hormone locus control region. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 21711161 |
| Cell Source: | HeLa |
| CVCL ID: | CVCL_0030 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay; TF-binding/chromatin assay |
| Low Throughput Method: | Luciferase reporter assay; Reporter assay; ChIP-qPCR/ChIP |
| Target gene : | GH1 |
| TF name : | CTCF |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| CTCF | Activation of anterior HOX genes in hindbrain development during early embryogenesis | reactome | 120 |
| CTCF | TGF_beta_Receptor | netpath | 220 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_03633 | chr17:62028371-62028917 | pituitary gland | epithelial cell | NA |
| E_03647 | chr17:62028371-62028917 | pituitary gland | epithelial cell | NA |
| E_03674 | chr17:62028378-62028924 | NA | malignant cell | NA |
| E_03676 | chr17:62028378-62028924 | NA | NA | NA |
| E_03677 | chr17:62028378-62028924 | NA | NA | NA |